Zika Virus and the Blood Supply: What Do We Know?

Transfusion Medicine Reviews

Volumn 31, Issue 1, 2017, Pages 1-10

  Jimenez, Alexandra ^a   Shaz, Beth H ^b   Bloch, Evan M ^c  

^a NEW YORK BLOOD CENTER   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Arbovirus; Blood safety; Blood transfusion; Communicable diseases; Emerging; Transfusion transmitted virus; Zika virus

Indexed keywords

ADVERSE OUTCOME; ARBOVIRUS; ASYMPTOMATIC INFECTION; BLOOD COMPONENT; CIRCULATION; CLINICAL FEATURE; DISEASE CARRIER; EPIDEMIC; HUMAN; INFECTION CONTROL; INFECTION RISK; LABORATORY DIAGNOSIS; REVIEW; VASCULARIZATION; VIRUS TRANSMISSION; ZIKA FEVER; BLOOD; BLOOD DONOR; COMMUNICABLE DISEASE; FEMALE; NEWBORN; PATHOGENICITY; PHYSIOLOGY; PREGNANCY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; TRANSMISSION; TRAVEL; UNITED STATES; VIROLOGY; ZIKA VIRUS;

BLOOD DONORS; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; RISK FACTORS; TRAVEL; UNITED STATES; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85002984407     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2016.08.001     Document Type: Review

References (124)

1. [1] World Health Organization, WHO statement on the first meeting of the International Health Regulations (2005) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations. 2016, WHO, Geneva.
2. [2] European Centre for Disease Prevention and Control, Zika virus infection: Zika outbreak in the Americas and the Pacific: Zika transmission in past 9 months. 2016, ECDC, Stockholm.
3. [3] AABB Zika Virus Symposium: blood & HCT/P safety. 2016 [Washington, DC].
4. [4] Kuno, G, Chang, GJ, Tsuchiya, KR, Karabatsos, N, Cropp, CB, Phylogeny of the genus Flavivirus. J Virol 72 (1998), 73–83.
5. [5] Dick, GW, Kitchen, SF, Haddow, AJ, Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 46 (1952), 509–520.
6. [6] Kirya, BG, A yellow fever epizootic in Zika forest, Uganda, during 1972: part 1: virus isolation and sentinel monkeys. Trans R Soc Trop Med Hyg 71 (1977), 254–260.
7. [7] Faye, O, Freire, CC, Iamarino, A, Faye, O, de Oliveira, JV, Diallo, M, et al. Molecular evolution of Zika virus during its emergence in the 20(th) century. PLoS Negl Trop Dis, 8, 2014, e2636.
8. [8] Lanciotti, RS, Kosoy, OL, Laven, JJ, Velez, JO, Lambert, AJ, Johnson, AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14 (2008), 1232–1239.
9. [9] Hayes, EB, Zika virus outside Africa. Emerg Infect Dis 15 (2009), 1347–1350.
10. [10] European Centre for Disease Prevention and Control, Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome (second update). 2016, ECDC, Stockholm.
11. [11] World Health Organization, Zika situation report—neurological syndrome and congenital anomalies. 2016, ed2016.
12. [12] European Centre for Disease Prevention and Control, Control ECfDPa, (eds.) Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome (sixth update), 2016, Internet, Stockholm.
13. [13] World Health Organization, Zika situation report. Neurological syndrome and congenital anomalies, 2016, World Health Organization.
14. [14] Centers for Disease Control and Prevention, Zika virus. Zika virus disease in the United States, 2015-2016. 2016, Centers for Disease Control and Prevention.
15. [15] Centers for Disease Control and Prevention. Zika virus. Pregnant women with any laboratory evidence of possible Zika virus infection in the United States and territories. Centers for Disease Control and Prevention; 2016.
16. [16] Whitcomb, D, Baby born in Hawaii with brain damage confirmed to have Zika infection. 2016, Internet, Reuters.
17. [17] First baby born with Zika-linked microcephaly in New York tri-state area. 2016, Fox News.
18. [18] Jenkins, C, First baby with Zika-related birth defect microcephaly born in Florida. 2016, Internet.
19. [19] Rabe, IB, Staples, JE, Villanueva, J, Hummel, KB, Johnson, JA, Rose, L, et al. Interim guidance for interpretation of Zika virus antibody test results. MMWR Morb Mortal Wkly Rep 65 (2016), 543–546.
20. [20] Centers for Disease Control and Prevention, National Notifiable Disease Surveillance System. Zika virus disease and Zika virus, congenital infection 2016 case definition, 2016.
21. [21] Diagne, CT, Diallo, D, Faye, O, Ba, Y, Faye, O, Gaye, A, et al. Potential of selected Senegalese Aedes spp. mosquitoes (Diptera: Culicidae) to transmit Zika virus. BMC Infect Dis, 15, 2015, 492.
22. [22] Grard, G, Caron, M, Mombo, IM, Nkoghe, D, Mboui Ondo, S, Jiolle, D, et al. Zika virus in Gabon (Central Africa)—2007: a new threat from Aedes albopictus?. PLoS Negl Trop Dis, 8, 2014, e2681.
23. [23] Centers for Disease Control and Prevention, Zika virus. Information for specific groups: vector surveillance & control: about estimated range of Aedes aegypti and Aedes albopictus in the United States, 2016 maps. 2016, CDC.
24. [24] Fauci, AS, Morens, DM, Zika virus in the Americas—yet another arbovirus threat. N Engl J Med 374 (2016), 601–604.
25. [25] Musso, D, Cao-Lormeau, VM, Gubler, DJ, Zika virus: following the path of dengue and chikungunya?. Lancet 386 (2015), 243–244.
26. [26] Centers for Disease Control and Prevention, Zika virus. Transmission & risks. 2016, Internet: CDC.
27. [27] Reiter, P, Lathrop, S, Bunning, M, Biggerstaff, B, Singer, D, Tiwari, T, et al. Texas lifestyle limits transmission of dengue virus. Emerg Infect Dis, 86–9, 2003.
28. [28] Centers for Disease Control and Prevention, West Nile virus in the United States: guidelines for surveillance, prevention, and control. 4th revision. 2013.
29. [29] Foy, BD, Kobylinski, KC, Chilson Foy, JL, Blitvich, BJ, Travassos da Rosa, A, Haddow, AD, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 17 (2011), 880–882.
30. [30] Atkinson, B, Hearn, P, Afrough, B, Lumley, S, Carter, D, Aarons, EJ, et al. Detection of Zika virus in semen. Emerg Infect Dis, 22, 2016, 940.
31. [31] European Centre for Disease Prevention and Control, Rapid risk assessment: Zika virus disease epidemic: potential association with microcephaly and Guillain-Barré syndrome. (Fourth update). 2016, ECDC, Stockholm.
32. [32] Deckard, DT, Chung, WM, Brooks, JT, Smith, JC, Woldai, S, Hennessey, M, et al. Male-to-male sexual transmission of Zika virus—Texas, January 2016. MMWR Morb Mortal Wkly Rep 65 (2016), 372–374.
33. [33] Davidson, A, Slavinski, S, Komoto, K, Rakeman, J, Weiss, D, Suspected female-to-male sexual transmission of Zika virus—New York City, 2016. MMWR Morb Mortal Wkly Rep 65 (2016), 716–717.
34. [34] Besnard, M, Lastere, S, Teissier, A, Cao-Lormeau, V, Musso, D, Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill, 2014, 20751.
35. [35] Pan American Health Organization, World Health Organization, Regional Office for the Americas, Epidemiological alert: neurological syndrome, congenital malformations, and Zika virus infection. Implications for public health in the Americas, 2015, World Health Organization, Washington, DC.
36. [36] European Centre for Disease Prevention and Control. Microcephaly in Brazil potentially linked to the Zika virus epidemic Stockholm ECDC, 2015.
37. [37] European Centre for Disease Prevention and Control, Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome. 2015, ECDC, Stockholm.
38. [38] Ventura, CV, Maia, M, Bravo-Filho, V, Gois, AL, Belfort, R Jr., Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet, 387, 2016, 228.
39. [39] Ventura, CV, Maia, M, Ventura, BV, Linden, VV, Araujo, EB, Ramos, RC, et al. Ophthalmological findings in infants with microcephaly and presumable intra-uterus Zika virus infection. Arq Bras Oftalmol 79 (2016), 1–3.
40. [40] Meaney-Delman, D, Hills, SL, Williams, C, Galang, RR, Lyengar, P, Hennenfent, AK, et al. Zika virus infection among U.S. pregnant travelers—August 2015–February 2016. MMWR Morb Mortal Wkly Rep 65 (2016), 211–214.
41. [41] Dupont-Rouzeyrol, M, Biron, A, O'Connor, O, Huguon, E, Descloux, E, Infectious Zika viral particles in breastmilk. Lancet, 387, 2016, 1051.
42. [42] Barzon, L, Pacenti, M, Berto, A, Sinigaglia, A, Franchin, E, Lavezzo, E, et al. Isolation of infectious Zika virus from saliva and prolonged viral RNA shedding in a traveller returning from the Dominican Republic to Italy, January 2016. Euro Surveill, 21(10), 2016.
43. [43] Leung, GH, Baird, RW, Druce, J, Anstey, NM, Zika virus infection in Australia following a monkey bite in Indonesia. Southeast Asian J Trop Med Public Health 46 (2015), 460–464.
44. [44] Pan American Health Organization, World Health Organization, Regional Office for the Americas. Zika virus infection and Zika fever: Frequently asked questions, 2016.
45. [45] Musso, D, Nhan, T, Robin, E, Roche, C, Bierlaire, D, Zisou, K, et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill, 19, 2014.
46. [46] Kuehnert, MJ, Basavaraju, SV, Moseley, RR, Pate, LL, Galel, SA, Williamson, PC, et al. Screening of blood donations for Zika virus infection—Puerto Rico, April 3–June 11, 2016. MMWR Morb Mortal Wkly Rep, 65, 2016.
47. [47] European Centre for Disease Prevention and Control, Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome (first update). 2016, ECDC, Stockholm.
48. [48] Herriman R. Transfusion-associated Zika virus reported in Brazil. Outbreak news today, 2015.
49. [49] Simpson, DI, Zika virus infection in man. Trans R Soc Trop Med Hyg 58 (1964), 335–338.
50. [50] Duffy, MR, Chen, TH, Hancock, WT, Powers, AM, Kool, JL, Lanciotti, RS, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 360 (2009), 2536–2543.
51. [51] Gourinat, AC, O'Connor, O, Calvez, E, Goarant, C, Dupont-Rouzeyrol, M, Detection of Zika virus in urine. Emerg Infect Dis 21 (2015), 84–86.
52. [52] Cao-Lormeau, VM, Blake, A, Mons, S, Lastere, S, Roche, C, Vanhomwegen, J, et al. Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387 (2016), 1531–1539.
53. [53] Leis, AA, Stokic, DS, Neuromuscular manifestations of West Nile virus infection. Front Neurol, 3, 2012, 37.
54. [54] Lebrun, G, Chadda, K, Reboux, AH, Martinet, O, Gauzere, BA, Guillain-Barre syndrome after chikungunya infection. Emerg Infect Dis 15 (2009), 495–496.
55. [55] Solomon, T, Dung, NM, Vaughn, DW, Kneen, R, Thao, LT, Raengsakulrach, B, et al. Neurological manifestations of dengue infection. Lancet 355 (2000), 1053–1059.
56. [56] Oehler, E, Watrin, L, Larre, P, Leparc-Goffart, I, Lastere, S, Valour, F, et al. Zika virus infection complicated by Guillain-Barre syndrome—case report, French Polynesia, December 2013. Euro Surveill, 19, 2014.
57. [57] Dejnirattisai, W, Supasa, P, Wongwiwat, W, Rouvinski, A, Barba-Spaeth, G, Duangchinda, T, et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat Immunol, 2016, 10.1038/ni.3515.
58. [58] Brasil, P, Pereira, JP Jr., Raja Gabaglia, C, Damasceno, L, Wakimoto, M, Ribeiro Nogueira, RM, et al. Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. N Engl J Med, 2016, 10.1056/NEJMoa1602412.
59. [59] Tang, H, Hammack, C, Ogden, SC, Wen, Z, Qian, X, Li, Y, et al. Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell 18 (2016), 587–590.
60. [60] Garcez, PP, Loiola, EC, Madeiro da Costa, R, Higa, LM, Trindade, P, Delvecchio, R, et al. Zika virus impairs growth in human neurospheres and brain organoids. Science 352 (2016), 816–818.
61. [61] Cauchemez, S, Besnard, M, Bompard, P, Dub, T, Guillemette-Artur, P, Eyrolle-Guignot, D, et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet 387 (2016), 2125–2132.
62. [62] Johansson, MA, Mier, Y, Teran-Romero, L, Reefhuis, J, Gilboa, SM, Hills, SL, Zika and the risk of microcephaly. N Engl J Med 375 (2016), 1–4.
63. [63] Pacheco, O, Beltran, M, Nelson, CA, Valencia, D, Tolosa, N, Farr, SL, et al. Zika virus disease in Colombia—preliminary report. N Engl J Med, 2016, 10.1056/NEJMoa1604037.
64. [64] Pan American Health Organization, World Health Organization, Regional Office for the Americas, Cumulative Zika suspected and confirmed cases reported by countries and territories in the Americas, 2015-2016. 2016, Pan American Health Organization, Washington, D.C.
65. [65] Sarmiento-Ospina, A, Vasquez-Serna, H, Jimenez-Canizales, CE, Villamil-Gomez, WE, Rodriguez-Morales, AJ, Zika virus associated deaths in Colombia. Lancet Infect Dis, 2016, 10.1016/S1473-3099(16)30006-8.
66. [66] Arzuza-Ortega, L, Polo, A, Perez-Tatis, G, Lopez-Garcia, H, Parra, E, Pardo-Herrera, LC, et al. Fatal sickle cell disease and Zika virus infection in girl from Colombia. Emerg Infect Dis 22 (2016), 925–927.
67. [67] Balm, MN, Lee, CK, Lee, HK, Chiu, L, Koay, ES, Tang, JW, A diagnostic polymerase chain reaction assay for Zika virus. J Med Virol 84 (2012), 1501–1505.
68. [68] Musso, D, Roche, C, Nhan, TX, Robin, E, Teissier, A, Cao-Lormeau, VM, Detection of Zika virus in saliva. J Clin Virol 68 (2015), 53–55.
69. [69] Bingham, AM, Cone, M, Mock, V, Heberlein-Larson, L, Stanek, D, Blackmore, C, et al. Comparison of test results for Zika virus RNA in urine, serum, and saliva specimens from persons with travel-associated Zika virus disease—Florida, 2016. MMWR Morb Mortal Wkly Rep 65 (2016), 475–478.
70. [70] Centers for Disease Control and Prevention, Memorandum: revised diagnostic testing for Zika, chikungunya, and dengue viruses in US public health laboratories. 2016, US Department of Health and Human Services, CDC, Atlanta, GA.
71. [71] Lustig, Y, Mendelson, E, Paran, N, Melamed, S, Schwartz, E, Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016. Euro Surveill, 21, 2016.
72. [72] European Centre for Disease Prevention and Control. Rapid risk assessment—zika virus infection outbreak, Brazil and the Pacific region. Stockholm: ECDC, 2016.
73. [73] Centers for Disease Control and Prevention, Emergency preparedness and response: CDC health advisory: recognizing, managing, and reporting Zika virus infections in travelers returning from central America, South America, the Caribbean, and Mexico. 2015.
74. [74] Barjas-Castro, ML, Angerami, RN, Cunha, MS, Suzuki, A, Nogueira, JS, Rocco, IM, et al. Probable transfusion-transmitted Zika virus in Brazil. Transfusion 56 (2016), 1684–1688.
75. [75] Boadle, A, Brazil reports Zika infection from blood transfusions: Reuters website. 2016.
76. [76] Marano, G, Pupella, S, Vaglio, S, Liumbruno, GM, Grazzini, G, Zika virus and the never-ending story of emerging pathogens and transfusion medicine. Blood Transfus 14 (2016), 95–100.
77. [77] Pealer, LN, Marfin, AA, Petersen, LR, Lanciotti, RS, Page, PL, Stramer, SL, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 349 (2003), 1236–1245.
78. [78] Macedo de Oliveira, A, Beecham, BD, Montgomery, SP, Lanciotti, RS, Linnen, JM, Giachetti, C, et al. West Nile virus blood transfusion–related infection despite nucleic acid testing. Transfusion 44 (2004), 1695–1699.
79. [79] Glynn, SA, Busch, MP, Dodd, RY, Katz, LM, Stramer, SL, Klein, HG, et al. Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century. Transfusion 53 (2013), 438–454.
80. [80] Food and Drug Administration (FDA) Guidance for Industry, Use of nucleic acid tests to reduce the risk of transmission of West Nile virus from donors of whole blood and blood components intended for transfusion. 2009, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research.
81. [81] Lanteri, MC, Busch, MP, Dengue in the context of “safe blood“ and global epidemiology: to screen or not to screen?. Transfusion 52 (2012), 1634–1639.
82. [82] Tan, LK, Lam, S, Low, SL, Tan, FH, NG, LC, Teo, D, Evaluation of pathogen reduction systems to inactivate dengue and chikungunya viruses in apheresis platelets suspended in plasma. Adv Infect Dis 3 (2013), 1–9.
83. [83] Chuang, VW, Wong, TY, Leung, YH, Ma, ES, Law, YL, Tsang, OT, et al. Review of dengue fever cases in Hong Kong during 1998 to 2005. Hong Kong Med J 14 (2008), 170–177.
84. [84] Tambyah, PA, Koay, ES, Poon, ML, Lin, RV, Ong, BK, Transfusion-Transmitted Dengue Infection Study G, Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med 359 (2008), 1526–1527.
85. [85] Stramer, SL, Linnen, JM, Carrick, JM, Foster, GA, Krysztof, DE, Zou, S, et al. Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion 52 (2012), 1657–1666.
86. [86] Sabino, EC, Loureiro, P, Lopes, ME, Capuani, L, McClure, C, Chowdhury, D, et al. Transfusion-transmitted dengue and associated clinical symptoms during the 2012 epidemic in Brazil. J Infect Dis 213 (2016), 694–702.
87. [87] Pozzetto, B, Memmi, M, Garraud, O, Is transfusion-transmitted dengue fever a potential public health threat?. World J Virol 4 (2015), 113–123.
88. [88] Matos, D, Tomashek, KM, Perez-Padilla, J, Munoz-Jordan, J, Hunsperger, E, Horiuchi, K, et al. Probable and possible transfusion-transmitted dengue associated with NS1 antigen-negative but RNA confirmed-positive red blood cells. Transfusion 56 (2016), 215–222.
89. [89] Conway, MJ, Watson, AM, Colpitts, TM, Dragovic, SM, Li, Z, Wang, P, et al. Mosquito saliva serine protease enhances dissemination of dengue virus into the mammalian host. J Virol 88 (2014), 164–175.
90. [90] Surasombatpattana, P, Ekchariyawat, P, Hamel, R, Patramool, S, Thongrungkiat, S, Denizot, M, et al. Aedes aegypti saliva contains a prominent 34-kDa protein that strongly enhances dengue virus replication in human keratinocytes. J Invest Dermatol 134 (2014), 281–284.
91. [91] Brouard, C, Bernillon, P, Quatresous, I, Pillonel, J, Assal, A, De Valk, H, et al. Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. Transfusion 48 (2008), 1333–1341.
92. [92] Weaver, SC, Lecuit, M, Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med 372 (2015), 1231–1239.
93. [93] Gerardin, P, Barau, G, Michault, A, Bintner, M, Randrianaivo, H, Choker, G, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Reunion. PLoS Med, 5, 2008, 60.
94. [94] Stramer, SL, Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. ISBT Sci Ser 9 (2014), 30–36.
95. [95] Simmons, G, Bres, V, Lu, K, Liss, NM, Brambilla, DJ, Ryff, KR, et al. High incidence of chikungunya virus and frequency of viremic blood donations during epidemic, Puerto Rico, USA, 2014. Emerg Infect Dis 22 (2016), 1221–1228.
96. [96] Center for Disease Control and Prevention, Chikungunya virus; transmission. 2015.
97. [97] Petersen, LR, Stramer, SL, Powers, AM, Chikungunya virus: possible impact on transfusion medicine. Transfus Med Rev 24 (2010), 15–21.
98. [98] Petersen, LR, Busch, MP, Transfusion-transmitted arboviruses. Vox Sang 98 (2010), 495–503.
99. [99] AABB, Association bulletin #16–03; Zika, dengue, and chikungunya viruses. February 1, 2016 ed. 2016 [Bethesda, MD].
100. [100] Food and Drug Administration (FDA), Recommendations for donor screening deferral, and product management to reduce the risk of transfusion-transmission of Zika virus: guidance for industry. 2016, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and. Research, Silver Spring, MD.
101. [101] AABB, Associate bulletin #16–04; Zika, Degue, and chikungunya viruses. 2016, Bethesda, MD, AABB.
102. [102] World Health Organization (WHO), Maintaining a safe and adequate blood supply during Zika virus outbreaks; interim guidance. WHO/ZIKV/HS/161, 2016, WHO.
103. [103] BRIEF-Hologic, Grifols say FDA approves Zika diagnostic test. 2016, Internet: Reuters.
104. [104] Naing, ZW, Scott, GM, Shand, A, Hamilton, ST, van Zuylen, WJ, Basha, J, et al. Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention. Aust N Z J Obstet Gynaecol 56 (2016), 9–18.
105. [105] Aubry, M, Richard, V, Green, J, Broult, J, Musso, D, Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination. Transfusion 56 (2016), 33–40.
106. [106] Musso, D, Richard, V, Broult, J, Cao-Lormeau, VM, Inactivation of dengue virus in plasma with amotosalen and ultraviolet A illumination. Transfusion 54 (2014), 2924–2930.
107. [107] Snyder, EL, Stramer, SL, Benjamin, RJ, The safety of the blood supply—time to raise the bar. N Engl J Med, 373, 2015, 882.
108. [108] Allain, JP, Bianco, C, Blajchman, MA, Brecher, ME, Busch, M, Leiby, D, et al. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Med Rev 19 (2005), 110–126.
109. [109] Kuklina, EV, Meikle, SF, Jamieson, DJ, Whiteman, MK, Barfield, WD, Hillis, SD, et al. Severe obstetric morbidity in the United States: 1998-2005. Obstet Gynecol 113 (2009), 293–299.
110. [110] Bloch, EM, Crookes, RL, Hull, J, Fawcus, S, Gangaram, R, Anthony, J, et al. The impact of human immunodeficiency virus infection on obstetric hemorrhage and blood transfusion in South Africa. Transfusion 55 (2015), 1675–1684.
111. [111] Bloch, EM, Simon, MS, Shaz, BH, Emerging infections and blood safety in the 21st century. Ann Intern Med, 2016, 10.7326/M15-1329.
112. [112] Aubry, M, Finke, J, Teissier, A, Roche, C, Broult, J, Paulous, S, et al. Seroprevalence of arboviruses among blood donors in French Polynesia, 2011-2013. Int J Infect Dis 41 (2015), 11–12.
113. [113] Vasquez, AM, Sapiano, MR, Basavaraju, SV, Kuehnert, MJ, Rivera-Garcia, B, Survey of blood collection centers and implementation of guidance for prevention of transfusion-transmitted Zika virus infection—Puerto Rico, 2016. MMWR Morb Mortal Wkly Rep 65 (2016), 375–378.
114. [114] Chen, LH, Wilson, ME, Non-vector transmission of dengue and other mosquito-borne flaviviruses. Dengue Bull 29 (2005), 18–30.
115. [115] Centers for Disease C, Prevention, et al. MMWR Morb Mortal Wkly Rep 51 (2002), 1135–1136.
116. [116] Centers for Disease Control and Prevention. West Nile virus; Transmission 2015. http://www.cdc.gov/westnile/transmission/.
117. [117] Pouliot, SH, Xiong, X, Harville, E, Paz-Soldan, V, Tomashek, KM, Breart, G, et al. Maternal dengue and pregnancy outcomes: a systematic review. Obstet Gynecol Surv 65 (2010), 107–118.
118. [118] Center for Disease Control and Prevention. Dengue Virus; Epidemiology; Transmission of the Dengue Virus 2014. http://www.cdc.gov/dengue/epidemiology/.
119. [119] Barthel, A, Gourinat, AC, Cazorla, C, Joubert, C, Dupont-Rouzeyrol, M, Descloux, E, Breast milk as a possible route of vertical transmission of dengue virus?. Clin Infect Dis 57 (2013), 415–417.
120. [120] Brathwaite Dick, O, San Martin, JL, Montoya, RH, del Diego, J, Zambrano, B, Dayan, GH, The history of dengue outbreaks in the Americas. Am J Trop Med Hyg 87 (2012), 584–593.
121. [121] Filipe, AR, Martins, CM, Rocha, H, Laboratory infection with Zika virus after vaccination against yellow fever. Arch Gesamte Virusforsch 43 (1973), 315–319.
122. [122] Carteaux, G, Maquart, M, Bedet, A, Contou, D, Brugieres, P, Fourati, S, et al. Zika virus associated with meningoencephalitis. N Engl J Med 374 (2016), 1595–1596.
123. [123] World Health Organization (WHO), Emergencies preparedness, response: Zika virus infection—Brazil and Colombia. 2015.
124. [124] Pan American Health Organization, World Health Organization, Regional Office for the Americas, Number of reported cases of chikungunya fever in the Americas, by country or territory 2015—cumulative cases. 2016, World Health Organization, Washington.